» Articles » PMID: 11458506

Quantitative Assessment of the Stem Cell Self-renewal Capacity

Overview
Specialty Science
Date 2001 Jul 19
PMID 11458506
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Little is known about the manner in which hematopoietic stem cells (HSCs) self-renew. To address this issue, we used a serum-free single-cell culture, followed by transplantation of cultured cells into lethally irradiated mice. CD34-negative or low, c-Kit-positive, Sca-1-positive, lineage marker-negative (CD34-KSL) cells are highly enriched for murine bone marrow HSCs. Successful long-term reconstitution with a single CD34-KSL cell enabled us to study in vitro self-renewal of HSC at clonal level. Using this clonal cell transplantation system, we examined the effect of various cytokines on CD34-KSL cells. Among the cytokines examined, stem cell factor (SCF) and thrombopoietin (TPO) were minimum cytokines to induce cell division of CD34-KSL cells most efficiently. Similarly, multilineage repopulating activity was detected in the cells derived from a significant portion of single cells after culture in the presence of TPO and SCF. However, SCF + IL-3, SCF + IL-6, or SCF + IL-11 + FL appeared to be less effective for self-renewal of HSCs. The activity of HSCs as indicated by repopulation unit (RU) remaining after culture with SCF and TPO was not so different from that of freshly isolated HSCs. However, there was a substantial loss of HSC number in these cultured cells. Taken together, this study provides definitive proof that one HSC can generate at least one HSC in vitro.

Citing Articles

Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells.

Donnelly H, Ross E, Xiao Y, Hermantara R, Taqi A, Doherty-Boyd W Nat Commun. 2024; 15(1):5791.

PMID: 38987295 PMC: 11237034. DOI: 10.1038/s41467-024-50054-0.


Improvement of multilineage hematopoiesis in hematopoietic stem cell-transferred c-kit mutant NOG-EXL humanized mice.

Ito R, Ohno Y, Mu Y, Ka Y, Ito S, Emi-Sugie M Stem Cell Res Ther. 2024; 15(1):182.

PMID: 38902833 PMC: 11191313. DOI: 10.1186/s13287-024-03799-w.


Lessons from early life: understanding development to expand stem cells and treat cancers.

Bain F, Che J, Jassinskaja M, Kent D Development. 2022; 149(20).

PMID: 36217963 PMC: 9724165. DOI: 10.1242/dev.201070.


Mesenchymal stromal cells in the bone marrow niche consist of multi-populations with distinct transcriptional and epigenetic properties.

Kanazawa S, Okada H, Hojo H, Ohba S, Iwata J, Komura M Sci Rep. 2021; 11(1):15811.

PMID: 34349154 PMC: 8338933. DOI: 10.1038/s41598-021-94186-5.


Hematopoietic Stem Cell Heterogeneity.

Jurecic R Adv Exp Med Biol. 2019; 1169:195-211.

PMID: 31487025 PMC: 7409779. DOI: 10.1007/978-3-030-24108-7_10.